Clinical Trial Update: Adjuvant Immune Checkpoint Inhibitors in Postoperative Hepatocellular Carcinoma

View source ↗

Summary

A completed clinical trial update assessing adjuvant immune checkpoint inhibitors in patients after hepatocellular carcinoma surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Guangxi Medical University | Conditions: Hepatocellular Carcinoma | Status: COMPLETED